# POSACONAZOLE

NDC: 0527-2133
Generic name: Posaconazole
Labeler / Manufacturer: Lannett Company Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, DELAYED RELEASE
Routes: ORAL
Marketing started: 20190828

FDA application: ANDA212411

## Active ingredients

- POSACONAZOLE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0527-2133"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0527-2133
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=94a9b028-a2bc-4f41-884d-2d6c536881fc